Tag: Vadastuximab talirine

Click the tags to see associated articles and topics

View Article Details

Seattle Genetics, Inc. (SGEN) Analysts See $-0.41 EPS

Added to Collection on: 2018-04-25 05:22:30

Tags for this article:

Clinical medicine

NASDAQ

Biotechnology

Drugs

Diffuse large B-cell lymphoma

S&P 500 INDEX - CBOE

Denintuzumab mafodotin

Click the tags to see associated articles and topics

View Article Details

What Next for Seattle Genetics Inc (NASDAQ:SGEN) Stock After Decrease in Shorted Shares?

Added to Collection on: 2018-06-08 19:48:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Seattle Genetics (NASDAQ:SGEN): HC Wainwright Reiterates “Buy” Rating Today, Has a Target of ...

Added to Collection on: 2018-07-26 20:29:49

Tags for this article:

SGN-CD19A

Click the tags to see associated articles and topics

View Article Details

$-0.28 EPS Expected for Seattle Genetics, Inc. (SGEN); Ativo Capital Management Has Decreased ...

Added to Collection on: 2019-04-08 01:20:30

Tags for this article:

Ativo Capital Management LLC

Drugs

Team SoloMid

Glembatumumab vedotin

Abu Dhabi SE Industrial Index

S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details

Bolt, Vor IPO Pricings Top $400 million Cap Huge Week for Life Science Financing

Added to Collection on: 2021-02-05 16:42:29

Tags for this article:

Antibody-drug conjugate

HER2/neu

Monoclonal antibody therapy

Trastuzumab

Click the tags to see associated articles and topics

View Article Details

GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2021 ...

Added to Collection on: 2021-06-23 14:03:45

Tags for this article:

Tumors of the hematopoietic and lymphoid tissues

Myelodysplastic syndrome

CD33

Leukemia

Cell therapy

Lintuzumab

GT Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details

STTK) (NASDAQ: MBRX) Quest For Solutions For Acute Myeloid Leukemia (AML) - menafn

Added to Collection on: 2024-06-17 21:19:34

Tags for this article:

Orphan drugs

Lintuzumab

Protein kinase inhibitors

CD135

7+3

Actinium Pharmaceuticals Inc.

Devimistat

Actimab-A

Click the tags to see associated articles and topics

View Article Details

FDA Grants Fast Track Designation to ICT01 Plus Azacitidine and Venetoclax in AML

Added to Collection on: 2024-09-18 22:15:18

Tags for this article:

7+3

Leukemia

Tyrosine kinase receptors

Lintuzumab

Click the tags to see associated articles and topics

View Article Details

Acute Myeloid Leukemia Pipeline Insight 2025: Akeso's FDA ODD for Ligufalimab, 100+ ...

Added to Collection on: 2025-09-16 23:20:04

Tags for this article:

Camidanlumab tesirine